"Whether it be by helping to improve one's intimacy with their partner, helping to conceive, or improving energy and overall health and well-being, every day is truly rewarding."

September's Member of the Month is Kristy Mardis, NP! You can learn more about Kristy and her work here!

A large number of patients with sexual dysfunction may also have neurological disorders that play a direct role in their sexual functioning. Sexual dysfunction and neurologic disorders are comorbidities that have a negative effect on overall quality of life, and it is recommended that they be treated in tandem. This article aims to briefly cover a variety of neurologic disorders and their direct effects on sexual dysfunction.

Since the 1940s, there have been conflicting theories and conclusions surrounding testosterone replacement therapy (TRT), and whether or not it is safe for hypogonadal men with or without a history of radically treated prostate cancer (PCa). This article will go over some international guidelines and recent research on how to approach TRT in hypogonadal PCa patients.

Dealing with breast cancer is not easy, for patients, families, and care providers alike. Even beyond the emotional and physical toll of cancer treatment, there are unacknowledged effects that every patient may face. Breast cancer survivors represent over 40% of all cancer survivors. Of these, around 50% report experiencing some sort of sexual difficulty, with 45% reporting sexual pain.

Patients may have questions about their options for managing and treating Peyronie’s disease. According to most urological societies, providers are advised to inform patients of their options to the fullest extent possible. Meaning, informing patients about risks, benefits, and efficacy of each option available, whether they’re experimental or not. In order to inform patients to the fullest extent, it’s important to know about each available option. This article intends to outline the basics of each option, including potential risks, benefits, and efficacy, with regard to AUA and CUA recommendations.

The Sexual Medicine Society of North America (SMSNA) is pleased to announce its endorsement of the newly released AUA Guideline: Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025).

Infertility, defined as the inability to conceive after one year of unprotected intercourse, affects approximately 15% of couples worldwide, with roughly 13.4% pre-menopausal women in the United States affected. This article aims to address options available to female patients and couples to have children and the processes in place to protect all parties involved.

On the third day of the 25th SMSNA Annual Fall Scientific Meeting, Dr. Sherita King discussed the challenges of diagnosing and treating idiopathic penile pain, particularly for conditions like hard flaccid syndrome. This type of pain, with no clear underlying cause, can be difficult to address, but Dr. King outlined an approach to guide practitioners.

At the second day of the 25th SMSNA Annual Fall Scientific Meeting, Dr. Petar Bajic and Dr. Daniela Wittmann shared crucial insights on the often underappreciated impact of androgen deprivation therapy (ADT) on sexual wellbeing and overall quality of life for prostate cancer patients.

At the second day of the 25th SMSNA Annual Fall Scientific Meeting, Dr. Stacy Loeb, a board-certified expert in lifestyle medicine, delivered an insightful presentation on the importance of lifestyle and diet for sexual health. She emphasized that plant-based diets, rich in minimally processed foods like legumes, fruits, vegetables, and whole grains, can significantly improve sexual function. These diets have been linked to a lower risk of erectile dysfunction and enhanced quality of life, particularly in prostate cancer survivors.